Last reviewed · How we verify

NCT04307433

Storytelling Intervention to Promote Cervical Cancer Screening Uptakes Among Malawian Women Living With Human Immunodeficiency Virus

Completed NA Last updated 30 September 2022
What this trial tests

NA trial testing Storytelling narrative videos on tablets in HIV/AIDS in 179 participants. Completed in 31 August 2022.

Timeline
21 October 2021
Primary endpoint
30 June 2022
31 August 2022

Quick facts

Lead sponsorUniversity of Massachusetts, Boston
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposeprevention
Enrollment179
Start date21 October 2021
Primary completion30 June 2022
Estimated completion31 August 2022
Sites1 location across Malawi

Drugs / interventions tested

Conditions studied

Sponsor

University of Massachusetts, Boston

Who can join

Adults 20 to 50, female only, with HIV/AIDS. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To develop a theory-based culturally-grounded storytelling-based intervention to increase cervical cancer screening among Malawian women living with HIV infection. Secondary objectives: To conduct a pilot randomized clinical trial (RCT) to examine the acceptability, feasibility and preliminary effectiveness of narrative intervention on cervical cancer screening prevention behavior.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for HIV/AIDS

Currently open trials in the same condition.

Other University of Massachusetts, Boston trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04307433.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing